113 related articles for article (PubMed ID: 14734697)
1. For ovarian cancer, an optimal treatment remains to be found.
Bankhead C
J Natl Cancer Inst; 2004 Jan; 96(2):96-7. PubMed ID: 14734697
[No Abstract] [Full Text] [Related]
2. The sequential multiple modality treatment of ovarian cancer.
Dembo AJ
Radiother Oncol; 1985 Apr; 3(3):187-92. PubMed ID: 3923573
[No Abstract] [Full Text] [Related]
3. Radiotherapeutic management of ovarian cancer.
Dembo AJ
Semin Oncol; 1984 Sep; 11(3):238-50. PubMed ID: 6435249
[No Abstract] [Full Text] [Related]
4. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary.
Wheelock J; Hancock K; Smith K
Cancer Treat Rep; 1987 Dec; 71(12):1275-6. PubMed ID: 3690537
[No Abstract] [Full Text] [Related]
5. Meta-analysis of cisplatin, doxorubicin, and cyclophosphamide versus cisplatin and cyclophosphamide chemotherapy of ovarian carcinoma.
Omura GA; Brady MF
Obstet Gynecol; 1993 Apr; 81(4):641-2. PubMed ID: 8459984
[No Abstract] [Full Text] [Related]
6. Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.
J Clin Oncol; 1991 Sep; 9(9):1668-74. PubMed ID: 1831495
[TBL] [Abstract][Full Text] [Related]
7. Sequential cisplatin--doxorubicin, early debulking in advanced ovarian cancer.
Heintz AP
Eur J Cancer; 1992; 28A(6-7):1009-10. PubMed ID: 1627364
[No Abstract] [Full Text] [Related]
8. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma.
Wils J; Blijham G; Naus A; Belder C; Boschma F; Bron H; Ceelen T; Eekhout A; von Erp J; Geelen P
J Clin Oncol; 1986 Jul; 4(7):1068-73. PubMed ID: 3723166
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of an advanced ovarian serous cystadenocarcinoma in pregnancy with cisplatin, adriamycin and cyclophosphamide (CAP) regimen. Case report.
Ohara N; Teramoto K
Clin Exp Obstet Gynecol; 2000; 27(2):123-4. PubMed ID: 10968352
[No Abstract] [Full Text] [Related]
10. Second-look laparotomy in ovarian carcinoma patients after 8 and after 12 courses of cisplatin-based chemotherapy.
Menczer J; Ben-Baruch G; Modan M; Brenner H
Gynecol Obstet Invest; 1989; 27(2):102-4. PubMed ID: 2731767
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of ovarian cancer].
Kato T; Nishimura H
Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
[No Abstract] [Full Text] [Related]
12. Chemotherapy for advanced ovarian cancer.
Omura GA
Lancet; 1987 Sep; 2(8560):689. PubMed ID: 2887974
[No Abstract] [Full Text] [Related]
13. Is paclitaxel/carboplatin really a useful regimen for ovarian cancer compared with platinum/doxorubicin/cyclophosphamide?
Sugiyama T
Int J Clin Oncol; 2006 Jun; 11(3):163. PubMed ID: 16850120
[No Abstract] [Full Text] [Related]
14. Lack of substantial five year disease-free survival by primary aggressive surgery and cisplatin-based chemotherapy or by salvage intraperitoneal cisplatin-based chemotherapy.
Piver MS; Baker TR; Driscoll DL
Eur J Gynaecol Oncol; 1990; 11(4):243-50. PubMed ID: 2245807
[No Abstract] [Full Text] [Related]
15. [A case of neo-JP therapy in the treatment of ovarian carcinoma].
Matsunami K; Takagi H; Hasegawa Y
Gan To Kagaku Ryoho; 1995 Jan; 22(1):153-5. PubMed ID: 7826073
[No Abstract] [Full Text] [Related]
16. Effective high-dose chemotherapy with autologous bone marrow infusion in resistant ovarian cancer.
Vriesendorp R; Aalders JG; Sleijfer DT; Postmus PE; Willemse PH; Bouma J; Mulder NH
Gynecol Oncol; 1984 Mar; 17(3):271-6. PubMed ID: 6368331
[TBL] [Abstract][Full Text] [Related]
17. [Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
Pickel H
Gynakol Rundsch; 1989; 29 Suppl 2():357-8. PubMed ID: 2693256
[No Abstract] [Full Text] [Related]
18. [Treatment of advanced ovarian carcinoma with cyclophosphamide, adriamycin and cisplatin: evaluation of the therapeutic response and analysis of the collateral effects].
Facchini V; Gadducci A; Ceccarelli P; Dell'Arciprete T; Del Bravo B; Bartolini T; Fioretti P
Ann Ostet Ginecol Med Perinat; 1986; 107(6):359-68. PubMed ID: 3566043
[No Abstract] [Full Text] [Related]
19. High versus low dose cisplatin in epithelial ovarian cancer.
Ghersi D; Parmar MK; Guthrie D; Williams C
Lancet; 1992 Sep; 340(8820):678-9. PubMed ID: 1355247
[No Abstract] [Full Text] [Related]
20. Re: Mucinous ovarian cancer.
Omura GA
Gynecol Oncol; 2005 Dec; 99(3):789; author reply 789-90. PubMed ID: 16125757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
